ICMR & Bharat Biotech Collaborate For COVID 19 Vaccine, As First Indigenous Testing Kit Also Gets Developed

In what can be dubbed as a much-needed good news, the Indian Council for Medical Research (ICMR) has announced a research collaboration with Bharat Biotech International Ltd (BBIL), to develop a COVID-19 vaccine.

ICMR has said in a statement that it has transferred the virus strain isolated at the National Institute of Virology, Pune to BBIL.

The social media post put out by ICMR said,

ICMR-NIV will provide continuous support to BBIL for vaccine development. ICMR and BBIL will seek fast-track approvals to expedite vaccine development, subsequent animal studies and clinical evaluation of the candidate vaccine.

Whereas the head of Bharat Biotech, Dr. Krishna Ella, has said that BBIL is “proud to participate in this project of national importance” and that they will do “everything to make this program successful”.

This news was also supplemented by a Tweet sent out by Health Minister, Dr. Harsh Vardhan, about National Institute of Virology and ICMR have also developed 1st indigenous human Elisa testing kit to combat COVID-19 outbreak.

We hope the tireless efforts by research bodies help us reach a sustainable culmination to fight against the deadly novel coronavirus.

Leave a Comment:

Your email address will not be published.